Zevra Therapeutics (ZVRA) announced the appointment of Alicia Secor to the Company’s Board of Directors. The Company announced the retirement of director Wendy Dixon, PhD, effective today.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- Zevra Therapeutics CFO Resignation Announced
- Zevra Therapeutics CFO R. LaDuane Clifton to step down
- Zevra Therapeutics: Strategic Focus on Miplyffa Drives Buy Rating Amid Promising Growth Prospects
- Zevra Therapeutics Reports Strong Q3 Earnings and Strategic Growth
- Zevra Therapeutics price target lowered to $24 from $29 at Cantor Fitzgerald